Prevention of hepatocellular carcinoma resulting from hepatitis B: are we there yet?
- PMID: 24316105
- PMCID: PMC5497489
- DOI: 10.1016/j.cgh.2013.11.027
Prevention of hepatocellular carcinoma resulting from hepatitis B: are we there yet?
Comment on
-
Antiviral therapy for chronic hepatitis B virus infection and development of hepatocellular carcinoma in a US population.Clin Gastroenterol Hepatol. 2014 May;12(5):885-93. doi: 10.1016/j.cgh.2013.09.062. Epub 2013 Oct 6. Clin Gastroenterol Hepatol. 2014. PMID: 24107395 Free PMC article.
References
-
- Weinbaum CM, Williams I, Mast EE, et al. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep. 2008;57:1–20. - PubMed
-
- Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74. - PubMed
-
- Iloeje UH, Yang HI, Jen CL, et al. Risk and predictors of mortality associated with chronic hepatitis B infection. Clin Gastroenterol Hepatol. 2007;5:921–931. - PubMed
-
- Chang Mei-Hwei, You San-Lin, Chen Chien-Jen, et al. Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study. J Natl Cancer Inst. 2009;101:1348–1355. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
